Lion Point Capital, LP Portfolio Holdings

Lion Point Capital, LP

  • $12.9 Million
  • Q4 2024

Lion Point Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $12.9 Million distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $2.53M, Milestone Pharmaceuticals Inc. with a value of $2.42M, Geron Corp with a value of $1.77M, Ardelyx, Inc. with a value of $1.73M, and Fennec Pharmaceuticals Inc. with a value of $1.24M.

Examining the 13F form we can see an decrease of $24.3M in the current position value, from $37.2M to 12.9M.

Lion Point Capital, LP is based out at New York, NY

Below you can find more details about Lion Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $12.9 Million
Healthcare: $12.9 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11B
$2.53 Million 19.59% of portfolio
36,700
Q4 2024 Reduced 29.69%
$61.8M
$2.42 Million 18.72% of portfolio
1,025,806
Q4 2024 Reduced 37.99%
$994M
$1.77 Million 13.69% of portfolio
500,000
Q4 2024 Reduced 20.63%
$824M
$1.73 Million 13.41% of portfolio
335,400
Q4 2024 Reduced 9.35%
$172M
$1.24 Million 9.56% of portfolio
195,700
Q4 2024 Reduced 8.98%
$5.46B
$1.11 Million 8.55% of portfolio
40,300
Q4 2024 Reduced 17.76%
$927M
$727,000 5.62% of portfolio
55,000
Q4 2024 Added 19.05%
$784M
$644,000 4.98% of portfolio
46,300
Q4 2024 Added 31.91%
$314M
$446,000 3.45% of portfolio
57,750
Q3 2024 Added 59.31%
$100M
$282,000 2.18% of portfolio
340,761
Q4 2023 Reduced 50.74%
$9.9M
$30,000 0.23% of portfolio
75,000
Q1 2024 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 31.67%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 22.42%
Kiniksa Pharmaceuticals LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 25.24%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Benitec Biopharma Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 58.97%
Bluebird Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 37.66%

Summary

  • Portfolio
  • No. of Stocks 19
  • Current Value $12.9 Million
  • Prior Value $37.2 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 1 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Lion Point Capital, LP Portfolio

Follow Lion Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lion Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email